Kristin Stephens

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, Massachusetts
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristin Stephens:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Chief Development Officer Common Stock 25.2K $129K $5.12 Apr 1, 2024 Direct
Syros Pharmaceuticals, Inc. Chief Development Officer Restricted Stock Units 23.3K $116K $4.98 Mar 31, 2024 Direct

Insider Reports Filed by Kristin Stephens

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2024 5 -$21.6K 4 Apr 2, 2024 Chief Development Officer
SYRS Syros Pharmaceuticals, Inc. Oct 31, 2023 3 -$12.6K 4 Nov 2, 2023 Chief Development Officer
SYRS Syros Pharmaceuticals, Inc. Mar 31, 2023 3 -$1.61K 4 Apr 4, 2023 Chief Development Officer
SYRS Syros Pharmaceuticals, Inc. Feb 16, 2023 1 $0 4 Feb 21, 2023 Chief Development Officer
SYRS Syros Pharmaceuticals, Inc. Oct 6, 2022 2 $0 4 Oct 11, 2022 Chief Development Officer
SYRS Syros Pharmaceuticals, Inc. Apr 1, 2022 1 -$15.8K 4 Apr 4, 2022 Chief Development Officer
SYRS Syros Pharmaceuticals, Inc. Feb 15, 2022 3 $0 4 Feb 17, 2022 Chief Development Officer
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 0 $0 3 Jun 10, 2021 Chief Development Officer